why choose us

Clinical Trials Search

Showing 10,440 of 132,366 result(s)
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

Status: NOT_YET_RECRUITING

Condition: Anatomic Stage I Breast Cancer

Interventions: Undergo endocrine therapy

Date: 2023-06-15

Phase 4 Study Evaluating the Safety of the Nasal Guide With Tyrvaya

Status: COMPLETED

Condition: Dry Eye

Interventions: Use of Nasal Guide with administration of Tyrvaya (varenicline solution 0.03 mg) BID

Date: 2023-06-15

Virtual Reality and Fear of Falling in Parkinson's Disease

Status: Completed

Condition: Parkinson

Interventions: Virtual environment that triggers fear of falling

Date: 2023-06-15

To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID

Status: Completed

Condition: Long Covid

Interventions: Participants will be treated with two infusions of BC 007 or placebo two weeks apart, according to a double-blind design

Date: 2023-06-15

Clinical Use of a Contraceptive Decision Aid and Patient Outcomes

Status: NOT_YET_RECRUITING

Condition: Contraceptive Usage

Interventions: Participants complete the Tuune contraceptive decision aid health questionnaire (Tuune for clinics) as part of their standard OBGYN clinic appointment

Date: 2023-06-15

Effects of Rock Climbing on Parkinson's Disease

Status: Completed

Condition: Parkinson Disease

Interventions: Vertical ascent of a surface specifically designed to elicit the skills that might be required to scale a naturally occurring rock formation

Date: 2023-06-15

A Feasibility Study of Topical Cannabinoids for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in Adults With Hormone Receptor-Positive Breast Cancer (CanAroma)

Status: Completed

Condition: Musculoskeletal Syndrome

Interventions: product contains 2210 mg CBD and less than 0.3% THC per 1.5 ounce jar.
Patients will be provided a 2-week supply of creams (3 jars for each 14 da

Date: 2023-06-15

Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients

Status: Completed

Condition: Obesity, Morbid

Interventions: A total of 24 hours of prophylactic respiratory support will be provided using NIV alternating with HFNC with total NIV usage of 16 hours and HFNC usa

Date: 2023-06-15

Clinical Trial of the ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Recurrent Brain Tumors

Status: NOT_YET_RECRUITING

Condition: Glioblastoma

Interventions: A non-toxic compound and inhibits the DNA damage response associated with radiation therapy.
• WSD-0628 radio sensitizes Glioblastoma cells.

Date: 2023-06-15

Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality

Status: Completed

Condition: Depression

Interventions: 9-weeks of weekly psychotherapy sessions focused on social reward exposure

Date: 2023-06-15